Skip to content

On board! Rehabilitation after colorectal cancer

On board! Rehabilitation after colorectal cancer - MIRANDA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00020822
Enrollment
1200
Registered
2020-02-18
Start date
2020-09-09
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C18 C19 C20

Interventions

Group 1: At the begin of rehabilitation (baseline): - self-administered questionnaires (see primary and secondary endpoints for further details) - measurement of height, weight and waist circumferenc

Sponsors

Deutsches Krebsforschungszentrum (DKFZ)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Colorectal cancer diagnosis (ICD-10 C18-20 and C21.8) - CRC therapy in last 12 months (surgical removal of tumor, radiation and/or chemotherapy (adjuvant or neoadjuvant)) - At least 3 weeks of in-patient rehabilitation in a cooperating clinic are planned - Sufficient knowledge of the German language and mental capability to be able to give written informed consent and comply with the study requirements

Exclusion criteria

Exclusion criteria: - Subjects who do not consent to participate or who are incapable of giving their own consent will be excluded

Design outcomes

Primary

MeasureTime frame
- Cancer-related fatigue assessed by using validated questionnaires (FACIT-F and EORTC-QLQ-FA12) in month 4, 7, 10 and after 1, 3, 5, 7, 10 years

Secondary

MeasureTime frame
- Overall and domain-specific quality of life assessed by using a validated questionnaire tool (EORTC-QLC C30) in month 4, 7, 10 and after 1, 3, 5, 7, 10 years - Colorectal cancer-specific quality of life assessed by using a validated questionnaire tool (EORTC-QLQ CR29) in month 10 - Distress in cancer assessed by using a validated questionnaire tool (QSC-R10) in month 10 - Functional well-being assessed by using a validated questionnaire tool (FACIT-F-FWB) in month 4, 7, 10 and after 1, 3, 5, 7, 10 years - Infection frequencies (total, upper respiratory and lower respiratory tract infections) assessed by self-report of study participants in month 4 and after 1, 3, 5, 7, 10 years - Return to work assessed by self-report of study participants and by using the count of paid working hours in month 4, 7, 10 and after 1, 3, 5, 7, 10 years - Disease-related early retirement assessed by self-report of study participants after 1 year - Subjective ability to work assessed by the short version of the Work Ability Index (WAI) in month 10 - Frailty assessed by using a validated questionnaire tool (FRAIL-Scale) after 1, 3, 5, 7, 10 years - Falls, fractures including (non-)vertebral and hip fractures assessed by self-report of study participants after 1, 3, 5, 7, 10 years - Depressive symptoms assessed by using a validated questionnaire tool (GDS-15) in month 4, 7, 10 and after 1, 3, 5, 7, 10 years - Depressive episodes assessed by self-report of study participants after 1, 3, 5, 7 and 10 years - Anxiety assessed by using a validated questionnaire tool (GAD-7) after 1 year - Cancer incidence assessed by self-report of study participants after 1, 3, 5, 7 and 10 years - Cancer mortality (ICD-10 code C00-C97, D00-D09 or D37-48 as leading cause of death) assessed by register matching after 1, 3, 5, 7 and 10 years - Colorectal-cancer mortality (ICD-10 code C18-C21 as leading cause of death) assessed by register matching after 1, 3, 5, 7 and 10 years - Cardiovascu

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026